Find a Tender
planned
Official procurement procedure
Drugs of Abuse and Wider Point of Care Testing
Analysers
Blood analysers
Blood-testing reagents
+6 more
UK
Published value
£280,000,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Shared Business Services Ltd (NHS SBS): "Drugs of Abuse and Wider Point of Care Testing". Published status: planned. Published value: £280,000,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Shared Business Services Ltd (NHS SBS) | Scope & Categories | Not published | Submission Window | planned No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £280,000,000 |
Bidder Intelligence · Authority Profile: NHS Shared Business Services Ltd (NHS SBS)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Shared Business Services Ltd (NHS SBS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
17.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 11 active published awards; 11 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Shared Business Services Ltd (NHS SBS) | Procedure methodNot published | Procurement categoryNot published |
Statusplanned | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published8 Apr 2021, 12:06 BST | Last source update8 Apr 2021, 12:06 BST | Recurring procurementNot published |
ClassificationAnalysers, Blood analysers, Blood-testing reagents, Checking and testing apparatus, Drug detection apparatus, Laboratory reagents, Laboratory services, Machines and apparatus for testing and measuring, Reagent strips | ||
Delivery area UK | ||
OCIDocds-h6vhtk-02a3a0 | ||
What is being bought
NHS SBS is looking to expand the scope of their current Point of Care Testing: Drugs of Abuse framework agreement to include the below potential areas –
• Rapid Drug Testing (oral, urine and hair)
• Pandemic Testing (Antigen & Antibody)
• Family Law Services including DNA Testing
• Blood Born Virus Testing
• Blood Spot Drug & Alcohol testing
• Alcohol Testing Devices, including Breath Analysers, Continuous Monitoring (SCRAM) and Associated Consumables
• Confirmation/Classification Testing/Screening of Non-Negative Samples
• Operational Outsourcing of Services
NHS SBS are open to expanding this scope further, suppliers should complete the RFI with their suggestions.
Innovation will continue to be a key focus of the framework agreement, awarded suppliers will have the option to add innovative products/services to the framework throughout the duration of the Agreement.
What changed
From the official release history
- Published value updated to £280,000,000
8 Apr 2021, 12:06 BST - Status changed to planned
8 Apr 2021, 12:06 BST - Official notice release published
8 Apr 2021, 12:06 BST - Buyer information updated
8 Apr 2021, 12:06 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplannedPublished valueNot publishedPrior Information Notice (PIN) for Drugs of Abuse and Wider Point of Care Testing framework agreement. NHS Shared Business Services (NHS SBS) are consulting on a proposal to tender for the provision of Drugs of Abuse and Wider Point of Care Testing to support NHS Organisations and the wider public sector to replace the existing framework agreement which will expire in December 2021. To help define and develop our national procurement strategy and help in the development of our service specification to meet the needs of NHS Organisations and wider Public Sectors, NHS SBS are engaging with potential providers prior to the release of any official tender documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
8 Apr 2021, 12:06 BST
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS Shared Business Services Ltd (NHS SBS)
Contracting authority GB-FTS-2029Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published